India to Australia: Allopurinol Export Trade Route
India has recorded 93 verified shipments of Allopurinol exported to Australia, representing a combined trade value of $19.7M USD. This corridor is served by 7 active Indian exporters, with an average shipment value of $211.4K USD. The leading Indian exporter is IPCA LABORATORIES LIMITED, which accounts for 83% of total export value with 38 shipments worth $16.3M USD. On the buying side, NA is the largest importer in Australia with $16.3M USD in purchases. The top 3 suppliers — IPCA LABORATORIES LIMITED, SANDOZ PRIVATE LIMITED, IPCA LABORATORIES LIMITED — together control 99% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Australia Allopurinol corridor is one of India's established pharmaceutical export routes, with 93 shipments documented worth a combined $19.7M USD. The route is dominated by IPCA LABORATORIES LIMITED, which alone accounts for roughly 83% of all export value, reflecting the consolidated nature of India's allopurinol manufacturing sector.
Across 7 active suppliers, the average shipment value stands at $211.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 72% of all shipments, consistent with allopurinol's non-urgent bulk-order profile.
Shipment activity peaks during UNAVAILABLE, with an average transit time of 15 days port-to-port. The route has recorded an annual growth rate of 17.5%, placing it at rank #19 among India's top allopurinol export destinations globally.
On the import side, key buyers of Indian allopurinol in Australia include NA, SANDOZ PTY LIMITED, APOTEX PTY LTD and 13 others. NA is the single largest importer with 32 shipments valued at $16.3M USD.
